JPWO2022181660A1 - - Google Patents

Info

Publication number
JPWO2022181660A1
JPWO2022181660A1 JP2023502465A JP2023502465A JPWO2022181660A1 JP WO2022181660 A1 JPWO2022181660 A1 JP WO2022181660A1 JP 2023502465 A JP2023502465 A JP 2023502465A JP 2023502465 A JP2023502465 A JP 2023502465A JP WO2022181660 A1 JPWO2022181660 A1 JP WO2022181660A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023502465A
Other versions
JP7449626B2 (ja
JPWO2022181660A5 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022181660A1 publication Critical patent/JPWO2022181660A1/ja
Publication of JPWO2022181660A5 publication Critical patent/JPWO2022181660A5/ja
Application granted granted Critical
Publication of JP7449626B2 publication Critical patent/JP7449626B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2023502465A 2021-02-26 2022-02-24 スクリーニング方法に使用するためのヒト脂肪肝モデル細胞 Active JP7449626B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021030911 2021-02-26
JP2021030911 2021-02-26
PCT/JP2022/007494 WO2022181660A1 (ja) 2021-02-26 2022-02-24 スクリーニング方法に使用するためのヒト脂肪肝モデル細胞

Publications (3)

Publication Number Publication Date
JPWO2022181660A1 true JPWO2022181660A1 (ja) 2022-09-01
JPWO2022181660A5 JPWO2022181660A5 (ja) 2023-07-13
JP7449626B2 JP7449626B2 (ja) 2024-03-14

Family

ID=83049072

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023502465A Active JP7449626B2 (ja) 2021-02-26 2022-02-24 スクリーニング方法に使用するためのヒト脂肪肝モデル細胞

Country Status (5)

Country Link
EP (1) EP4299720A1 (ja)
JP (1) JP7449626B2 (ja)
CN (1) CN116917462A (ja)
CA (1) CA3211975A1 (ja)
WO (1) WO2022181660A1 (ja)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014204713A (ja) * 2013-03-21 2014-10-30 秋田県 肝細胞分化ステージを評価する新規測定法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3157984B2 (ja) 1994-04-11 2001-04-23 科学技術振興事業団 初代培養肝細胞の継代培養系
CA2146735C (en) 1994-04-11 2007-02-20 Chise Tateno Liver parenchymal cells having clonal growth ability, method for obtaining same, method for subculturing same, and subculturing system of primary hepatocytes
JP3266766B2 (ja) 1994-08-23 2002-03-18 科学技術振興事業団 ローン性増殖能を有する肝実質細胞とその取得方法、並びにその継代培養方法
JPH0915225A (ja) 1995-04-28 1997-01-17 Tosoh Corp 血清リポタンパク質の分析方法
JP3014322B2 (ja) 1996-05-28 2000-02-28 科学技術振興事業団 小型肝細胞の培養方法
JP3211941B2 (ja) 1996-12-26 2001-09-25 科学技術振興事業団 ヒト小型肝細胞の取得方法と、この細胞の初代培養および継代培養方法
JP2002045087A (ja) 2000-05-19 2002-02-12 Japan Science & Technology Corp キメラ動物
WO2007052789A1 (ja) 2005-11-04 2007-05-10 Skylight Biotech Inc. 大血管障害を判別するためのリポタンパク質の分析方法
JP2007228962A (ja) 2006-01-31 2007-09-13 Hiroshima Industrial Promotion Organization ヒト肝細胞キメララットの作製方法
WO2008001614A1 (fr) 2006-06-29 2008-01-03 Hiroshima Industrial Promotion Organization Modèle animalier de stéatohépatite non alcoolique et modèle animalier de stéatose hépatique
JP5871412B2 (ja) 2012-03-27 2016-03-01 株式会社トランスジェニック ヒト化マウス
JP7379934B2 (ja) 2019-08-26 2023-11-15 マツダ株式会社 車両の後部構造
JP7039045B2 (ja) * 2019-08-26 2022-03-22 株式会社フェニックスバイオ ヒト脂肪肝モデル細胞

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014204713A (ja) * 2013-03-21 2014-10-30 秋田県 肝細胞分化ステージを評価する新規測定法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BIOMEDICAL RESEARCH (TOKYO), vol. 41, no. 1, JPN6022018145, 1 February 2020 (2020-02-01), pages 33 - 42, ISSN: 0005191958 *
J. BIOL. MACROMOL., vol. 21, no. 1, JPN6023027046, 20 January 2021 (2021-01-20), pages 51 - 52, ISSN: 0005191957 *

Also Published As

Publication number Publication date
JP7449626B2 (ja) 2024-03-14
WO2022181660A1 (ja) 2022-09-01
EP4299720A1 (en) 2024-01-03
CN116917462A (zh) 2023-10-20
CA3211975A1 (en) 2022-09-01

Similar Documents

Publication Publication Date Title
BR112023005462A2 (ja)
BR112021014123A2 (ja)
BR112023012656A2 (ja)
BR112022009896A2 (ja)
BR112022024743A2 (ja)
BR112023009656A2 (ja)
BR102021018859A2 (ja)
BR102021015500A2 (ja)
BR102021007058A2 (ja)
BR102020022030A2 (ja)
BR112023011738A2 (ja)
BR112023016292A2 (ja)
BR112023004146A2 (ja)
BR112023011610A2 (ja)
BR112023011539A2 (ja)
BR112023008976A2 (ja)
BR112023006729A2 (ja)
BR102021020147A2 (ja)
BR102021018926A2 (ja)
BR102021018167A2 (ja)
BR102021017576A2 (ja)
BR102021016837A2 (ja)
BR102021016551A2 (ja)
BR102021016375A2 (ja)
BR102021016176A2 (ja)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230509

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230509

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20230509

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230704

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231107

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231215

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240130

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240226

R150 Certificate of patent or registration of utility model

Ref document number: 7449626

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150